5-90495709-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006467.3(POLR3G):c.280G>A(p.Val94Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000576 in 1,597,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006467.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLR3G | NM_006467.3 | c.280G>A | p.Val94Ile | missense_variant | 4/8 | ENST00000651687.1 | NP_006458.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLR3G | ENST00000651687.1 | c.280G>A | p.Val94Ile | missense_variant | 4/8 | NM_006467.3 | ENSP00000498469.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151800Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000463 AC: 11AN: 237658Hom.: 0 AF XY: 0.0000620 AC XY: 8AN XY: 129062
GnomAD4 exome AF: 0.0000595 AC: 86AN: 1445642Hom.: 0 Cov.: 30 AF XY: 0.0000432 AC XY: 31AN XY: 718316
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151800Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74114
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2024 | The c.280G>A (p.V94I) alteration is located in exon 4 (coding exon 3) of the POLR3G gene. This alteration results from a G to A substitution at nucleotide position 280, causing the valine (V) at amino acid position 94 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at